Davide Seminati
Monza, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Validation of QuANTUM-derived tumor cell fraction for molecular testing in high-grade serous tubo-ovarian carcinoma.
Journal: NPJ precision oncology
Published: October 19, 2025
Next-generation radiomic sequencing in non-small cell lung cancer: an alternative model to predict mutations from [18F]FDG PET/CT.
Journal: Therapeutic advances in respiratory disease
Published: October 09, 2025
Liquid biopsy in prostate cancer: A multidisciplinary expert consensus statement.
Journal: Tumori
Published: September 29, 2025
Beyond Tissue in the Era of Liquid Biopsy: Pathologists' Perspectives and Insights.
Journal: Cytopathology : official journal of the British Society for Clinical Cytology
Published: June 30, 2025
Storage Time and DNA Quality Determine BRCA1/2 Sequencing Success in Prostate Cancer: A Multicentre Analysis with Therapeutic Implications.
Journal: Cancers
Published: April 08, 2025
The routine use of a digital tool for the tumor cell fraction quantification in molecular pathology: an international validation of QuANTUM.
Journal: Pathologica
Published: October 04, 2024
Pathology Laboratory Archives: Conservation Quality of Nucleic Acids and Proteins for NSCLC Molecular Testing.
Journal: Journal of personalized medicine
Published: February 22, 2024
Economic assessment of NGS testing workflow for NSCLC in a healthcare setting.
Journal: Heliyon
Published: February 06, 2024
Impact and Reproducibility of In-House Targeted Next-Generation Sequencing Biomarker Testing in Non-Small-Cell Lung Cancer: An Italian Multi-Institutional Experience.
Journal: The Journal of molecular diagnostics : JMD
Published: January 15, 2024
Last Updated: 09/26/2026